Adipocyte

Adipocyte is an open-access, peer-reviewed journal given to the biology, physiology and pathophysiology of adipose tissue. It was founded in 2012 by Landes Bioscience of Austin, Texas, and has been published by Taylor & Francis in Philadelphia since 2015.《脂肪细胞》是一本开放获取的同行评审期刊，专事脂肪组织的生物学、生理学与病理生理学。该刊 2012 年由设在得克萨斯州奥斯汀的 Landes Bioscience 创办，2015 年起转由费城的 Taylor & Francis 出版。

Its remit stretches from the molecular mechanisms that govern adipocyte formation to the tissue-level and systemic processes in which fat takes part, and basic, translational and clinical work are all admitted.其范围从支配脂肪细胞形成的分子机制，延伸到脂肪参与的组织层面与全身性过程，基础研究、转化研究与临床研究都在接收之列。

Obesity, diabetes, cardiovascular disease and cancer all come within reach whenever adipose tissue is central to the question, a breadth that follows from the organ's endocrine role.只要脂肪组织是问题的核心，肥胖、糖尿病、心血管疾病与癌症都在涉猎之内，这种广度源自该器官的内分泌角色。

Clarivate recorded a 2025 Journal Impact Factor of 3.3 and a five-year value of 3.6, which put the title 100th among 198 journals in endocrinology and metabolism.Clarivate 记录的 2025 年影响因子为 3.3，五年影响因子为 3.6，该刊在内分泌与代谢类目 198 种期刊中列第 100 位。

Scope

• The premise is stated plainly in the journal's own description, which treats adipose tissue as the largest endocrine organ in the body and builds its remit from that claim.该刊的自我描述把前提说得直白，脂肪组织被视作体内最大的内分泌器官，刊物的范围即由此建立。

• Adipocyte development, differentiation and function form the core, so a paper on lineage commitment, on a transcription factor cascade or on mature cell physiology belongs here.脂肪细胞的发育、分化与功能构成核心，关于谱系定向、转录因子级联或成熟细胞生理的论文都属于此。

• Molecular mechanisms and cellular dynamics are named in the overview, which brings signalling pathways, vesicle traffic and the turnover of lipid droplets into view.概览点名了分子机制与细胞动态，信号通路、囊泡运输与脂滴周转因此进入视野。

• Work at the tissue level sits beside work on systemic interactions, and a study of local inflammation may be read against one of whole-body insulin sensitivity.组织层面的研究与全身性相互作用的研究并列，局部炎症的研究可以与全身胰岛素敏感性的研究对读。

• Metabolic regulation of the adipocyte is a standing interest, covering lipolysis, lipogenesis and the uptake and storage of fatty acid.脂肪细胞的代谢调控是长期关注点，涵盖脂解、脂质合成以及脂肪酸的摄取与储存。

• Inflammation of adipose tissue draws steady attention, since macrophage infiltration and cytokine output tie an expanded fat mass to metabolic derangement.脂肪组织炎症受到持续关注，因为巨噬细胞浸润与细胞因子释放把脂肪量的扩张同代谢紊乱绑在一起。

• Endocrine signalling is treated as a subject in its own right, and the adipokines released by fat are followed into liver, muscle, vasculature and brain.内分泌信号被视为独立课题，脂肪释放的脂肪因子被追踪到肝脏、肌肉、血管与脑。

• Energy storage and thermoregulation, the two tasks long assigned to this tissue, remain inside the scope even as the endocrine account has grown.能量储存与体温调节是长期赋予这一组织的两项任务，在内分泌解释不断扩充之后仍留在范围之内。

• Reproductive function, angiogenesis, apoptosis, blood pressure, coagulation, fibrinolysis, immunity and general metabolic homeostasis are all listed among the processes fat contributes to.生殖功能，血管生成与细胞凋亡列入脂肪参与的过程，血压，凝血，纤维蛋白溶解，免疫与整体代谢稳态也在其列。

• Skin and reconstructive surgery have a place as well, since fat is the material of grafting and the substrate of several dermatological conditions.皮肤与修复外科同样有一席之地，脂肪既是移植的材料，也是若干皮肤病变的基质。

• Clinical relevance is encouraged, and a laboratory finding is expected to be tied to obesity, diabetes, cardiovascular disease or cancer where such a link exists.临床相关性受到鼓励，实验室发现只要确有关联，就要同肥胖、糖尿病、心血管疾病或癌症联系起来。

• Original research, comprehensive reviews and short communications are the three forms named in the overview, and each is judged on the mechanistic substance it carries.原创研究、综合性综述与短通讯是概览点名的三种体裁，三者都按所载机制内容的实质来评判。

• The journal describes itself as a platform for interdisciplinary dialogue, so a paper that joins two specialties is welcome where a single-field journal would send it away.该刊自述为跨学科对话的平台，把两个专业连接起来的论文在此受到欢迎，而在单一领域的期刊那里可能被退回。

History

• Volume one appeared in 2012 under Landes Bioscience, an independent publisher based in Austin, Texas, and the American imprint dates from that arrangement.第一卷于 2012 年在 Landes Bioscience 名下问世，这家独立出版社设在得克萨斯州奥斯汀，刊物的美国出版地即由此而来。

• Two numbers were assigned at launch, 2162-3945 and 2162-397X, and both have stayed with the title through every change of publisher.创刊时分配了两个刊号，2162-3945 与 2162-397X，两者历经出版方更迭一直随刊。

• Its founders presented it as the first international peer-reviewed journal of its kind, a multi-disciplinary forum given exclusively to every aspect of adipose tissue.创办者把它呈现为同类中第一本国际同行评审期刊，一个专事脂肪组织各个方面的多学科论坛。

• That claim rested on a turn in the field, in which fat was recast from an inert store into a dynamic endocrine organ.这一说法依托于领域的转向，脂肪从惰性的储存物被重新理解为能动的内分泌器官。

• From the 2015 volume the imprint reads Philadelphia, and Taylor & Francis has published the journal ever since.自 2015 年卷起，出版地记为费城，此后刊物一直由 Taylor & Francis 出版。

• Landes Bioscience had joined that group, and the editorial work moved with the title from Texas to the East Coast.Landes Bioscience 并入该集团之后，编辑工作随刊物从得克萨斯迁往东海岸。

• Volume numbering has run unbroken at one volume a year, from volume 1 in 2012 to volume 15 in 2026. Four numbered issues filled each volume until volume 8, when the journal moved to continuous publication and articles took numbers instead.卷次未曾中断，每年一卷，从 2012 年的第 1 卷延续到 2026 年的第 15 卷。第 8 卷之前每卷编有四期，此后改为连续出版，文章以编号标识。

• PubMed has indexed the journal from volume 1, and PubMed Central holds a deposited version of every article.PubMed 自第 1 卷起收录该刊，PubMed Central 存有每篇文章的存档版本。

• MEDLINE came later, at volume 5 number 1 in 2016, four years after the first issue had gone out.MEDLINE 的收录来得较晚，始于 2016 年第 5 卷第 1 期，此时距创刊号已过去四年。

• Reading has been free from the start, and Clarivate puts the gold share of the output at 100 per cent, so no subscriber wall stands between a paper and its reader.阅读从一开始就免费，Clarivate 记录的金色开放获取比例为 100%，论文与读者之间没有订阅墙。

• The impact factor stood at 3.553 in 2022, eased to 3.5 in 2023, fell to 3.1 in 2024 and recovered to 3.3 in 2025.影响因子 2022 年为 3.553，2023 年微降至 3.5，2024 年落到 3.1，2025 年回升至 3.3。

• Output stays small, 35 articles in the 2025 volume, while the citation total of 1708 and a cited half-life of 6.2 years point to a compact readership.载文量保持在小规模，2025 年卷为 35 篇，总被引 1708 次与被引半衰期 6.2 年指向一个精炼的读者群。

• In the 2025 assessment the title sat just under the median of its category, with a JCI of 0.72 and a percentile of 49.7.2025 年评估中，该刊略低于类目中位，JCI 为 0.72，百分位为 49.7。

Editors

• The journal describes itself as peer reviewed, and a manuscript is read by working scientists before any editorial decision is reached.刊物自述为同行评审期刊，稿件在形成编辑决定之前由在职科研人员阅读。

• A multi-disciplinary remit shapes the board, which draws reviewers from adipocyte biology, endocrinology and the metabolic specialties the papers come from.多学科的范围塑造了编委会，评审人取自脂肪细胞生物学、内分泌学以及稿件所属的代谢专业。

• Basic, translational and clinical submissions are read side by side, and the question put to each is what it adds to the understanding of adipose tissue.基础、转化与临床稿件并列送审，向每一篇提出的问题是它为理解脂肪组织增加了什么。

• Original research, reviews and short communications are the forms the overview names, and a review is expected to cover its ground comprehensively.原创研究、综述与短通讯是概览点名的体裁，综述要求把所选题目覆盖周全。

• Manuscripts enter through the publisher's online system, and a cover letter setting out the advance is required with the submission.稿件经出版方的在线系统提交，随稿须附一封说明研究进展的投稿信。

• Reports reach the handling editor with a recommendation attached, and the decision letter tells the authors what has to be done.评审报告连同处理建议送到责任编辑手中，决定函告诉作者必须完成哪些事项。

• A revised manuscript usually goes back to the reviewers who saw the first version, which keeps the judgement consistent from round to round.修改稿通常回到读过初版的评审人手中，各轮判断因此保持一致。

• Where a paper sits between two fields, the handling editor may take an extra opinion instead of forcing it into a single camp.若稿件处在两个领域的交界处，责任编辑可以另行征询意见，不必把它归入单一门类。

• Editorial matter and correspondence are printed beside the research, which gives readers a place to contest a result that has already appeared.社论与读者来信同研究论文并列刊出，读者因此有地方对已发表的结果提出异议。

• No submission charge is levied, and the cost of open access is met by an article processing charge payable once a paper is accepted.投稿不收取费用，开放获取的成本由录用后支付的文章处理费承担。